
Sign up to save your podcasts
Or


In this episode, we explore the complex pharmacological management of mixed mania, a challenging bipolar presentation affecting up to 40% of manic episodes. Why do traditional mood stabilizers like lithium fall short, and which second-generation antipsychotics emerge as first-line treatments for this dual-symptom condition?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.
By Psychopharmacology Institute4.6
270270 ratings
In this episode, we explore the complex pharmacological management of mixed mania, a challenging bipolar presentation affecting up to 40% of manic episodes. Why do traditional mood stabilizers like lithium fall short, and which second-generation antipsychotics emerge as first-line treatments for this dual-symptom condition?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.

74 Listeners

142 Listeners

3,369 Listeners

160 Listeners

1,149 Listeners

1,349 Listeners

732 Listeners

168 Listeners

579 Listeners

473 Listeners

735 Listeners

12 Listeners

189 Listeners

150 Listeners

59 Listeners